Oklahoma Foundation for Cardiovascular Research — Oklahoma City, Oklahoma

Oklahoma Foundation for Cardiovascular Research is a clinical research site located in Oklahoma City, Oklahoma, United States 73120.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Oklahoma Foundation for Cardiovascular Research has participated in 27 clinical trials with 1 currently active.

Therapeutic areas: Coronary Artery Disease, Left Ventricular Dysfunction, Sudden Cardiac Death.

Sponsors: Brigham and Women's Hospital, Spectranetics Corporation, Boston Scientific Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma Foundation for Cardiovascular Research?

Oklahoma Foundation for Cardiovascular Research has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma Foundation for Cardiovascular Research conducted?

Oklahoma Foundation for Cardiovascular Research has 27 clinical trials on record, with 1 currently active. Their work covers Coronary Artery Disease, Left Ventricular Dysfunction, Sudden Cardiac Death.

Is Oklahoma Foundation for Cardiovascular Research accredited by Crixeo Clinical Trials?

Oklahoma Foundation for Cardiovascular Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma Foundation for Cardiovascular Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.